Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CTI BIOPHARMA CORP (CTI)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Total revenues  53.932.914.62.30.00.00.00.0
            Revenue growth        -100.0%-100.0%
Cost of goods sold  3.52.31.20.30.00.00.00.0
Gross profit  50.430.513.42.00.00.00.00.0
            Gross margin  93.5%92.9%91.8%87.9%    
Selling, general and administrative   [+]84.885.878.066.656.236.827.220.8
Research and development  36.935.737.237.739.137.935.232.1
Other operating expenses  8.510.6 11.0    
EBITDA   [+]-77.8-100.0-111.6-112.7-94.8-74.2-61.9-52.4
            EBITDA margin  -144.3%-304.4%-763.1%-4908.7%    
Depreciation and amortization  2.01.61.20.70.50.50.50.5
EBIT   [+]-79.8-101.6-112.7-113.4-95.3-74.8-62.4-52.9
            EBIT margin  -147.9%-309.1%-770.9%-4939.5%    
Interest expense  13.110.87.94.32.41.20.70.6
Other income (expense), net   [+]-0.10.0-0.2-0.2-0.2-0.1-0.1-4.0
Pre-tax income  -93.0-112.3-120.8-117.8-97.9-76.1-63.2-57.5
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -93.0-112.3-120.8-117.8-97.9-76.1-63.2-57.5
            Net margin  -172.4%-341.8%-826.0%-5133.6%    
   
Basic EPS   [+]($0.84)($1.07)($1.23)($1.25)($1.11)($0.91)($0.81)($0.78)
Diluted EPS   [+]($0.84)($1.07)($1.23)($1.25)($1.11)($0.91)($0.81)($0.78)
   
Shares outstanding (basic)   [+]111.2105.098.194.088.283.478.473.7
Shares outstanding (diluted)   [+]111.2105.098.194.088.283.478.473.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy